Use App
AI Agent
Trending
News
Earnings
All
DIA
1.15%
SPY
0.20%
QQQ
0.58%
Trending
PANW
18.44%
BABA
2.60%
UNH
10.27%
GLD
3.12%
MSTR
6.25%
P
2.38%
ASTS
7.43%
SLS
6.08%
ZIM
0.57%
CAPR
3.21%
Feed
News
Sentiment
Fundamentals
Info
Home
Symbol
FTHI
News
Exchange:
NASDAQ
·
Updated 04:15 PM EST
FTHI News
News
all
press releases
Novo Nordisk To Cut Ozempic, Wegovy Prices By Up To 50%
Ozempic and Wegovy will start at a list price of $675 a month, effective Jan. 1, 2027, according to the company.
Stocktwits
Full Article
NVO Stock Continues To Decline Pre-Market After Monday’s Crash Amid CagriSema Setback – But Tuesday Brings Some Hope From China
Developed in partnership with United Laboratories International Holdings, Novo Nordisk said that UBT251 delivered up to 19.7% mean weight loss after 24 weeks in a phase 2 trial in China.
Stocktwits
Full Article
Why Is NVO Stock Falling Pre-Market Today?
The company stated that CagriSema demonstrated 23% weight loss in people with obesity, failing to meet its primary endpoint.
Stocktwits
Full Article
1
Advertisement
|
Remove ads.
Home
Watchlist
Trending
News
Explore
Profile